The Digital Revolution Meets The Human Brain = Pervasive Neurotech June 30 th , 2015 Alvaro Fernandez & Nikhil Sriraman
Aug 13, 2015
The Digital
Revolution Meets
The Human Brain
= Pervasive
Neurotech
June 30th, 2015
Alvaro Fernandez & Nikhil
Sriraman
The team behind the new Pervasive
Neurotechnology report
Alvaro Fernandez
Editor-In-Chief
Nikhil Sriraman
IP Analyst
Brian Gurewitz
Technology Analyst
Olivier Oullier
Science Advisor
Today’s Agenda
1-1.20pm ET: Five Key Trends Driving
Neurotechnology to Become Pervasive
1.20-1.40pm ET: How Nielsen, Advanced
Neuromodulation Systems, Medtronic,
Microsoft and Brainlab emerged as
leading IP Holders
1.40-2pm ET: Q&A
Five key trends and insights
1. Exponential growth since 2010, close to/ supporting
commercialization
2. Large companies developing significant portfolios,
often under the radar
3. Evolution from invasive to pervasive impact on
medicine, health, entertainment and business
4. Multi-sensor, multi-variable analysis and use of data
(EEG, eye-tracking, heart rate, computer use,
patient…)
5. Aggressive “build” AND strategic/ tactical “buy”
Today’s Agenda
1-1.20pm ET: Five Key Trends Driving
Neurotechnology to Become Pervasive
1.20-1.40pm ET: How Nielsen, Advanced
Neuromodulation Systems, Medtronic,
Microsoft and Brainlab emerged as
leading IP Holders
1.40-2pm ET: Q&A
How we identified the population of
non-invasive neurotech patent filings
4K+ US non-invasive
neurotech patents
10K+ GLOBAL pubs
yielded w/ similar
process
How we assessed patent portfolios
The SharpBrains’ IP Strength Index:
Quantity + Quality
Volume + Relevance Fwd Cites + Scope + Key Patents
IP portfolio strength of 800+ organizations assessed
via SharpBrains Index (Report includes detailed
profiles of top 30, and ranks top 100)
How the Leading IP Holders emerged
#1: Nielsen
(NYSE:NLSN)
#1: Nielsen
(NYSE:NLSN)
#2: Advanced Neuromodulation Systems
(St Jude Medical -- NYSE: STJ)
#3: Medtronic
(NYSE:MDT)
#4: Microsoft
(NASDAQ:MSFT)
#4: Microsoft
(NASDAQ:MSFT)
#5: Brainlab
206-page report includes
Chapter I. Scoping the
Opportunity
Chapter II. The State of
Pervasive Neurotechnology
Patents
Chapter III. The Patent
Holders: Ranking of Top 100
Assignees, and Detailed
Profiles of 30 Leaders
Chapter IV. Analysis of 50
key Active Patents
Check out the full
Table of Contents &
Figures
Individual License………..….$395
Enterprise License…………$3,995
Up to 10 users
Tailored report of patent
landscape
Competitive analysis
1-hour conference call/
webinar